BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iasella CJ, Winstead RJ, Moore CA, Johnson BA, Feinberg AT, Morrell MR, Hayanga JWA, Lendermon EA, Zeevi A, McDyer JF, Ensor CR. Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors. Transplantation 2018;102:171-7. [PMID: 28691954 DOI: 10.1097/TP.0000000000001873] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ohm B, Jungraithmayr W. B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications. Front Immunol 2022;13:845867. [DOI: 10.3389/fimmu.2022.845867] [Reference Citation Analysis]
2 Small B, Au J, Brink H, Shah I, Strah H. Induction and maintenance immunosuppression in lung transplantation. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-021-01225-x] [Reference Citation Analysis]
3 Xiu MX, Liu ZT, Tang J. Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies. Int Immunopharmacol 2020;87:106827. [PMID: 32791489 DOI: 10.1016/j.intimp.2020.106827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Cristea O, Karadkhele G, Kitchens WH, Vasanth P, Larsen CP, Badell IR. Belatacept Conversion in Kidney After Liver Transplantation. Transplant Direct 2021;7:e780. [PMID: 34712780 DOI: 10.1097/TXD.0000000000001229] [Reference Citation Analysis]
5 Nishimura CD, Pulanco MC, Cui W, Lu L, Zang X. PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies. Trends Mol Med 2021;27:207-19. [PMID: 33199209 DOI: 10.1016/j.molmed.2020.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tang C, Wang W, Xue Y, Yang J, Khan R. Effect of MMF Immunosuppression Based on CNI Reduction on CNI-Related Renal Damage after Lung Transplantation. Journal of Healthcare Engineering 2022;2022:1-7. [DOI: 10.1155/2022/8099684] [Reference Citation Analysis]
7 Sharma D, Sharma N. A potential drug in the armamentarium of post-cardiac transplantation immunosuppression: belatacept. Indian J Thorac Cardiovasc Surg 2020;36:625-8. [PMID: 33100623 DOI: 10.1007/s12055-020-00991-4] [Reference Citation Analysis]
8 Benvenuto LJ, Anderson MR, Arcasoy SM. New frontiers in immunosuppression. J Thorac Dis 2018;10:3141-55. [PMID: 29997983 DOI: 10.21037/jtd.2018.04.79] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
9 El Boghdadly Z, Sarwar S, Lustberg ME. Infectious Challenges with Novel Antibody–Based Therapies. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00753-2] [Reference Citation Analysis]
10 Chandrashekaran S, Crow Pharm SA, Shah SZ, Arendt Pharm CJ, Kennedy CC. Immunosuppression for Lung Transplantation: Current and Future. Curr Transplant Rep 2018;5:212-9. [PMID: 30740294 DOI: 10.1007/s40472-018-0199-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Chung PA, Dilling DF. Immunosuppressive strategies in lung transplantation. Ann Transl Med 2020;8:409. [PMID: 32355853 DOI: 10.21037/atm.2019.12.117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]